Jorge Arango, MD
Ophthalmology · Dothan, ALNPI 1295764983
Payments from drug & device makers
Across 105 payments — averaging $31.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$708
- Regeneron Healthcare Solutions, Inc.$494
- Alimera Sciences, Inc.$381
- Astellas Pharma US Inc$355
- Integra Lifesciences Corporation$245
- Genentech USA, Inc.$182
- plus $993 from 13 others
What the payments were for
- Food & beverage$3,358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $708 |
| Regeneron Healthcare Solutions, Inc. | 11 | $494 |
| Alimera Sciences, Inc. | 20 | $381 |
| Astellas Pharma US Inc | 7 | $355 |
| Integra Lifesciences Corporation | 2 | $245 |
| Genentech USA, Inc. | 7 | $182 |
| ANI Pharmaceuticals, Inc. | 8 | $171 |
| Sun Pharmaceutical Industries Inc. | 1 | $138 |
| Coherus Oncology, Inc. | 2 | $137 |
| Apellis Pharmaceuticals, Inc. | 2 | $123 |
| Novartis | 3 | $101 |
| Aerin Medical Inc. | 1 | $88 |
| Kala Pharmaceuticals, Inc. | 1 | $88 |
| Sandoz | 2 | $49 |
| Stryker | 1 | $32 |
| Alcon | 1 | $21 |
| Carl Zeiss Meditec USA, Inc. | 1 | $17 |
| Harrow Eye, LLC | 1 | $16 |
| Carl Zeiss Meditec, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acclarent Aera$245
- Inspira Air$245
- TruDi Probe$245
- Izervay$140
- BROMSITE$138
- RELIEVA SPINPLUS NAV$129
- EYLEA HD$125
- Cimerli$116
How this compares
$3,358 in reported general payments places this provider in the 65th percentile of 197 ophthalmology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 83 | $3,233 |
| Prednisolone Acetate | 53 | $2,510 |
| Difluprednate | 18 | $2,199 |
| Bromfenac Sodium | 19 | $1,745 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 21 | $374 |
| Latanoprost | 34 | $290 |
| Timolol Maleate | 34 | $271 |
| Prednisone | 12 | $61 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Dothan
- Sebastian HeersinkDothan$3.9M
- Harsha SenDothan$140K
- Marnix HeersinkDothan$19K
- Kirk SturridgeDothan$11K
- Aaron McKinleyDothan$8K
- Warren ThompsonDothan$6K
- Marius HeersinkDothan$3K
- Bret FisherHomewood$821K
- Caroline WatsonHuntsville$292K
- Ronald GrossFairhope$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.